Table 4.
ROC curve analysis
| Variable | AUROC (95%CI) | P Value |
|---|---|---|
| Day 1 | ||
| TNF-α | 0.661 (.509–.812) | 0.049 |
| IL-6 | 0.797 (.675–.918) | 0.000 |
| IL-β | 0.628 (.473–.782) | 0.118 |
| APACHE II | 0.858 (.752–.964) | 0.000 |
| SOFA | 0.707 (.563–.851) | 0.074 |
| Day 3 | ||
| TNF-α | 0.684 (.521-.848) | 0.043 |
| IL-6 | 0.799 (.669–.928) | 0.001 |
| IL-β | 0.559 (.364–.753) | 0.518 |
| APACHE II | 0.848 (.734–.936) | 0.000 |
| SOFA | 0.765 (.622–.908) | 0.004 |
| Day 7 | ||
| TNF-α | 0.701 (.514–.889) | 0.052 |
| IL-6 | 0.899 (.801–.998) | 0.000 |
| IL-β | 0.552 (.312–.792) | 0.615 |
| APACHE II | 0.861 (.740–.982) | 0.000 |
| SOFA | 0.792 (.621–.962) | 0.005 |
AUROC, area under the receiver operating characteristic curve; CI, confidence interval; IL, interleukin; TNF, tumor necrosis factor; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment.